UK Pharma Co. Becomes First Ever Permitted By Gov To Produce High-THC Medicinal Cannabis

January 17, 2023 · Markets Insider

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East.

What Happened: This is the first company in the United Kingdom to be granted a Good Manufacturing Practice or GMP registration by the Medicines and Healthcare products Regulatory Agency to produce medical marijuana on UK soil.

The move follows seven harvests and extractions in 2022 and the facility’s inspection by MHRA in the fourth quarter.

Why It Matters

Founded in 2018, the same year the UK legalized medical marijuana, Celadon Pharmaceuticals is positioned to take its fair share of a market projected to surpass £1bn by 2026, according to an analysis from cannabis market intelligence firm Prohibition Partners.

At the moment, UK patients rely on imported products, which often results in delays and high costs, Celadon recently said.

“With the receipt of GMP registration, Celadon has joined a very select group of cannabis-focused pharmaceutical companies globally,” said James Short, the company’s CEO. “This is a tremendous milestone for the Company given the significant capital and regulatory requirements in this sector.”

Moreover, Celadon claims that the move makes it one of few global companies with the capacity to produce an EU GMP-grade high tetrahydrocannabinol cannabinoid API.

What’s Next

Prior to the sale of high-THC medicinal cannabis in the UK, the Home Office needs to update the company’s current license to reflect its GMP status.

“Whilst there is no guarantee that the Home Office will update the current license, nor any timeframe for this, the directors are confident that the license will be updated in due course,” Celadon said in a statement.


The UK opened its first specialized medical cannabis clinic in 2019. The Manchester-based facility kicked off operations after the UK rescheduled certain cannabis products allowing medical professionals to prescribe them. (Full Story)

In categories:International Medicinal
Next Post

Botanical Specialist Linnea Scores Narcotics License To Produce, Export High THC

Swissmedic, the surveillance authority for medicines and medical devices, granted Linnea SA a narcotics license at the end of 2022. This allows the company to help bring a pharmaceutical level of quality to this emerging cannabinoid industry, which is projected to grow from $28.26 billion in 2021…
Previous Post

How Is Colombia Selling and Shipping Thousands of Pounds of Weed to the US and Europe, Already? - Resolution 539

Think cannabis prices have found a bottom in the US and Canada? Think again as low-cost providers like Colombia have started shipping cannabis and cannabis products around the world at much lower costs than the US and Canada can compete with the current…
Random Post

RI House OKs bill to legalize ‘magic mushrooms’ statewide

Rhode Island is one step closer to decriminalizing so-called “magic mushrooms” statewide. The House approved legislation Monday that would allow Rhode Islanders to possess up to one ounce of psilocybin or grow magic mushrooms at home for personal use. It would also,…
Random Post

New York Governor Signs Cannabis Banking Compliance Bill

New York Governor Kathy Hochul recently signed a bill designed to facilitate banking compliance between licensed cannabis businesses and financial institutions. The measure, Senate Bill S1047, was sponsored by Senator Jeremy Cooney and Assemblymember Crystal Peoples-Stokes, both Democrats. Hochul signed…
Random Post

Kentucky, Wisconsin Lawmakers Introduce Marijuana Legalization Bills

Lawmakers in two of the 12 remaining states that have yet to legalize cannabis – Kentucky and Wisconsin – will have the option of approving limited reforms which could turn the tide, but both measures still have a long way…
Random Post

Dwindling legislative clock suggests Texas' cannabis reform bills will die in the state Senate

With a week left in the Texas Legislature's current session, political observers said it's increasingly unlikely the state will see any progress on cannabis reform. Earlier this session, the Texas House passed a proposal to broaden the state's medical marijuana program — one…